Zimbabwe has declined a substantial American health deal valued at $367m (£272m) over five years over Washington's request for sensitive data.
This rejection came to light following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesman later explained that the US was demanding access to health data for scientific study and commercial purposes but was not willing to share the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for continued talks to secure a deal suitable to all parties so the nation's critical HIV treatment initiative can be sustained.
Wider Context
This development comes after a comparable situation in neighbouring Kenya, where a high court blocked a related deal with the US after legal challenges were filed about the safety of Kenyans' health data.
Since resuming office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had managed assistance for the US government, but Trump argued its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and accountability.
As per reports, Sixteen nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy through American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.
"Effectively, our country would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our citizens if a future disease outbreak emerge."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were disrupting systems already established through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This system is designed to guarantee that when a nation provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," he added.
"We encourage continued discussions with our American counterparts on how subsequent collaboration might be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Response
Medical experts said it acknowledged the government's concerns, but recommended that talks should continue since much of the nation's Aids initiatives were funded by foreign aid.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group said.
The situation highlights the ongoing debate between receiving crucial foreign assistance and protecting local interests in an increasingly data-driven world.